Assurant, Inc. (AIZ)
Official siteFINANCIAL SERVICES • INSURANCE - PROPERTY & CASUALTY • NYSE
Market Cap: $15.80B
Last updated: Nov 17, 2026 at 11:05 AM ET
Assurant, Inc. (AIZ) Stock Forecast
Analysts expect Assurant (AIZ) to earn $24.31 per share in the fiscal year ending Dec 31, 2026, on revenue of $14.05B. Of 7 analysts, 7 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 7 ratings average 1.57, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 3 | 42.9% |
| Buy | 4 | 57.1% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 7
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 0.7% and revenue estimates rise 7.3%.
- Fiscal year ending Dec 31, 2026
- $24.31
- EPS consensus, revenue $14.05B
- Fiscal year ending Dec 31, 2027
- $24.47
- EPS consensus, revenue $15.08B
- Next report
- Feb 8, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $24.31 | $24.10 to $24.52 | 6 | $14.05B | $13.99B to $14.11B | 3 |
| Dec 31, 2027 | $24.47 | $23.57 to $26.00 | 7 | $15.08B | $14.67B to $15.48B | 3 |
Quarterly Estimates
The EPS consensus rises from $5.73 for the quarter ending Dec 31, 2026 to $6.18 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $5.73 | $4.93 to $6.35 | 9 | $3.63B | $3.44B to $3.89B | 6 |
| Mar 31, 2027 | $6.18 | $5.92 to $6.85 | 4 | $3.62B | $3.59B to $3.64B | 2 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 4 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 2 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
| Quarter ending Mar 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 10.1% from $22.08.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $24.31 | $22.47 | $22.36 | $22.27 | $22.08 | +10.1% |
| Fiscal year ending Dec 31, 2027 | $24.47 | $23.45 | $23.43 | $23.43 | $23.16 | +5.7% |
| Quarter ending Mar 31, 2027 | $6.18 | $6.04 | $6.04 | $6.04 | $6.14 | +0.7% |
Frequently Asked Questions About AIZ
What is the AIZ stock forecast?
Consensus analyst estimates put Assurant's EPS at $24.31 for the fiscal year ending Dec 31, 2026, on revenue of $14.05B. The consensus rating from 7 analysts is Buy.
How do analysts rate AIZ stock?
Of 7 analysts covering Assurant, 3 rate it Strong Buy, 4 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from AIZ next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $24.31, with estimates from $24.10 to $24.52 from 6 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $24.47, with estimates from $23.57 to $26.00 from 7 analysts.
What revenue do analysts expect from Assurant next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $14.05B, with estimates from $13.99B to $14.11B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $15.08B, with estimates from $14.67B to $15.48B.
How many analysts cover AIZ?
7 analysts rate Assurant stock, and 6 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
AIZ pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors